Literature DB >> 9602683

Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin.

W G McCluggage1, J Burton, P Maxwell, J M Sloan.   

Abstract

AIMS: To investigate the immunohisto-chemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin. Also, to determine whether immunostaining with this antibody is useful in differentiating between adrenal cortical neoplasms and other tumours involving the adrenal gland that might mimic them.
METHODS: Normal adrenal tissue (n = 20) and specimens from cases of adrenal hyperplasia (n = 13), adrenal cortical adenoma (n = 15), adrenal cortical carcinoma (n = 4), phaeochromocytoma (n = 8), and adrenal metastatic tumour (n = 7) were stained with a monoclonal antibody against the alpha subunit of human inhibin.
RESULTS: Positive staining with the anti-alpha inhibin monoclonal antibody was seen in all normal adrenal glands. Immunoreactivity was largely confined to the inner cell layers of the adrenal cortex, with no staining of the adrenal medulla. All hyperplastic adrenal glands and adrenal cortical adenomas and carcinomas were also immunoreactive. The other tumours studied were negative.
CONCLUSIONS: There is consistent immunoreactivity with the anti-alpha inhibin monoclonal antibody in normal adrenal cortex and in hyperplastic and neoplastic adrenal cortical lesions. In the normal adrenal cortex, positive staining is mainly confined to the zona reticularis. Other neoplasms involving the adrenal gland are negative. Immunohistochemical staining with anti-alpha inhibin monoclonal antibody, performed as part of a panel, may prove to be of value in the distinction between adrenal cortical carcinoma and phaeochromocytoma or metastatic tumour.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9602683      PMCID: PMC500504          DOI: 10.1136/jcp.51.2.114

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Gonadal and extragonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions.

Authors:  H Meunier; C Rivier; R M Evans; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

2.  Immunohistochemical staining of ovarian granulosa cell tumors with monoclonal antibody against inhibin.

Authors:  W G McCluggage; P Maxwell; J M Sloan
Journal:  Hum Pathol       Date:  1997-09       Impact factor: 3.466

3.  Immunohistochemical expression of inhibin/activin subunits in epithelial and granulosa cell tumours of the ovary.

Authors:  D S Arora; I E Cooke; T S Ganesan; J Ramsdale; S Manek; F M Charnock; N P Groome; M Wells
Journal:  J Pathol       Date:  1997-04       Impact factor: 7.996

4.  Alpha-inhibin gene expression occurs in the ovine adrenal cortex, and is regulated by adrenocorticotropin.

Authors:  R J Crawford; V E Hammond; B A Evans; J P Coghlan; J Haralambidis; B Hudson; J D Penschow; R I Richards; G W Tregear
Journal:  Mol Endocrinol       Date:  1987-10

5.  What is the function of adrenal inhibins?

Authors:  R Voutilainen
Journal:  Eur J Endocrinol       Date:  1995-03       Impact factor: 6.664

6.  Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary.

Authors:  M Rishi; L N Howard; G L Bratthauer; F A Tavassoli
Journal:  Am J Surg Pathol       Date:  1997-05       Impact factor: 6.394

7.  Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. A report of three cases with late metastasis, being previously misinterpreted as hemangiopericytoma.

Authors:  P Flemming; A Wellmann; H Maschek; H Lang; A Georgii
Journal:  Am J Surg Pathol       Date:  1995-08       Impact factor: 6.394

8.  Circulating immunoreactive inhibin levels during the normal human menstrual cycle.

Authors:  R I McLachlan; D M Robertson; D L Healy; H G Burger; D M de Kretser
Journal:  J Clin Endocrinol Metab       Date:  1987-11       Impact factor: 5.958

9.  Inhibin as a marker for granulosa-cell tumors.

Authors:  R E Lappöhn; H G Burger; J Bouma; M Bangah; M Krans; H W de Bruijn
Journal:  N Engl J Med       Date:  1989-09-21       Impact factor: 91.245

10.  In vivo and in vitro evidence for the production of inhibin-like immunoreactivity in human adrenocortical adenomas and normal adrenal glands: relatively high secretion from adenomas manifesting Cushing's syndrome.

Authors:  Y Nishi; M Haji; R Takayanagi; T Yanase; S Ikuyama; H Nawata
Journal:  Eur J Endocrinol       Date:  1995-03       Impact factor: 6.664

View more
  9 in total

Review 1.  A diagnostic approach to adrenal cortical lesions.

Authors:  Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 2.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

3.  Pathology of the adrenal cortex: a reappraisal of the past 25 years focusing on adrenal cortical tumors.

Authors:  Mauro Papotti; Eleonora Duregon; Marco Volante; Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

Review 4.  Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms.

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

5.  Immunohistochemical distinction of metastases of renal cell carcinoma to the adrenal from primary adrenal nodules, including oncocytic tumor.

Authors:  Hongmei Li; Ondrej Hes; Gregory T MacLennan; Daniel C Eastwood; Kenneth A Iczkowski
Journal:  Virchows Arch       Date:  2015-02-19       Impact factor: 4.064

6.  N-cadherin expression in adrenal tumors: upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinoma.

Authors:  Amir Khorram-Manesh; Håkan Ahlman; Svante Jansson; Ola Nilsson
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

7.  Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis.

Authors:  Thomas J Giordano; Dafydd G Thomas; Rork Kuick; Michelle Lizyness; David E Misek; Angela L Smith; Donita Sanders; Rima T Aljundi; Paul G Gauger; Norman W Thompson; Jeremy M G Taylor; Samir M Hanash
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

8.  Symptomatic intraspinal oncocytic adrenocortical adenoma.

Authors:  Jens Schittenhelm; Florian H Ebner; Patrick Harter; Antje Bornemann
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

9.  Inhibin alpha-subunit (INHA) expression in adrenocortical cancer is linked to genetic and epigenetic INHA promoter variation.

Authors:  Johannes Hofland; Jacobie Steenbergen; Jacoba M Voorsluijs; Michael M P J Verbiest; Ronald R de Krijger; Leo J Hofland; Wouter W de Herder; Andre G Uitterlinden; Richard A Feelders; Frank H de Jong
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.